On the same day, the FDA also republished its interim 503A Bulks List with notable updates, announcing its intent to remove twelve peptide bulk drug substances from Category 2 (Bulk Drug Substances that Raise Significant Safety Concerns) within seven calendar days
None of these are FDA-approved cognitive drugs, and the right consideration, if any, depends entirely on a clinical evaluation rather than a chart
With no head-to-head study, comparing the two requires stitching together trials that differ in population, comparator, endpoint, and duration a chain with several weak links
BPC 157 also protects nerve cells preventing memory loss and damage in lab tests
That said, researchers may find it useful to have a bit of background on past GHK-Cu dosing protocols: Minimum Effective Dose The lowest known doses of GHK-Cu administered to test subjects involve the application of skin creams and topical ointments
Hydroxocobalamin is safe to use during pregnancy and breastfeeding, with dosing generally following the standard schedule
